Siebner, Thomas Hartwig
Hove, Jens Dahlgaard
Madelung, Christopher Fugl
Hulme, Oliver James
Bendtsen, Flemming
Siebner, Hartwig Roman
Barløse, Mads
Article History
Received: 7 December 2023
Accepted: 25 March 2024
First Online: 15 April 2024
Competing interests
: Hartwig R. Siebner has received honoraria as speaker from Sanofi Genzyme, Denmark and Novartis, Denmark, as consultant from Sanofi Genzyme, Denmark and as editor-in-chief (Neuroimage Clinical) and senior editor (NeuroImage) from Elsevier Publishers, Amsterdam, The Netherlands. He has received royalties as book editor from Springer Publishers, Stuttgart, Germany and from Gyldendal Publishers, Copenhagen, Denmark. Jens D. Hove has received honoraria as speaker and consultant from Astra Zeneca, Denmark and Novo Nordisk, Denmark. Flemming Bendtsen has received honoraria as a consultant for Ferring Pharmaceuticals, Denmark. None of the competing interests listed above are directly related to this project. The other authors declare no competing interests.